Stefan Blaas

2.6k total citations
28 papers, 622 citations indexed

About

Stefan Blaas is a scholar working on Pulmonary and Respiratory Medicine, Infectious Diseases and Epidemiology. According to data from OpenAlex, Stefan Blaas has authored 28 papers receiving a total of 622 indexed citations (citations by other indexed papers that have themselves been cited), including 13 papers in Pulmonary and Respiratory Medicine, 7 papers in Infectious Diseases and 7 papers in Epidemiology. Recurrent topics in Stefan Blaas's work include Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Respiratory Support and Mechanisms (7 papers) and Pleural and Pulmonary Diseases (4 papers). Stefan Blaas is often cited by papers focused on Chronic Obstructive Pulmonary Disease (COPD) Research (9 papers), Respiratory Support and Mechanisms (7 papers) and Pleural and Pulmonary Diseases (4 papers). Stefan Blaas collaborates with scholars based in Germany, Netherlands and United States. Stefan Blaas's co-authors include Felix Herth, Dirk‐Jan Slebos, Bernd Salzberger, Wolfgang Gesierich, Christian Witt, Juergen Hetzel, Romain Kessler, Martin Hetzel, Gaëtan Deslée and Stefan Aretz and has published in prestigious journals such as American Journal of Respiratory and Critical Care Medicine, CHEST Journal and Thorax.

In The Last Decade

Stefan Blaas

27 papers receiving 609 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Stefan Blaas Germany 10 343 127 124 112 103 28 622
Vui Heng Chong Brunei 15 334 1.0× 15 0.1× 47 0.4× 428 3.8× 44 0.4× 83 741
O Leopardi Italy 11 487 1.4× 117 0.9× 8 0.1× 60 0.5× 213 2.1× 23 803
Daniel Hoefer Austria 14 57 0.2× 172 1.4× 30 0.2× 389 3.5× 97 0.9× 38 750
Corinne Levy France 9 140 0.4× 73 0.6× 23 0.2× 198 1.8× 21 0.2× 37 434
José Echave-Sustaeta Spain 12 602 1.8× 13 0.1× 41 0.3× 153 1.4× 19 0.2× 29 697
H T Winer-Muram United States 15 316 0.9× 18 0.1× 18 0.1× 129 1.2× 31 0.3× 26 584
Thomas Pfeiffer United States 11 29 0.1× 28 0.2× 59 0.5× 93 0.8× 29 0.3× 21 616
Kristine E. Konopka United States 10 409 1.2× 17 0.1× 32 0.3× 39 0.3× 15 0.1× 23 692
Hideaki Oka Japan 9 104 0.3× 39 0.3× 27 0.2× 41 0.4× 11 0.1× 50 370
Joyce S. Davis United States 9 68 0.2× 33 0.3× 63 0.5× 86 0.8× 87 0.8× 11 388

Countries citing papers authored by Stefan Blaas

Since Specialization
Citations

This map shows the geographic impact of Stefan Blaas's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Stefan Blaas with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Stefan Blaas more than expected).

Fields of papers citing papers by Stefan Blaas

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Stefan Blaas. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Stefan Blaas. The network helps show where Stefan Blaas may publish in the future.

Co-authorship network of co-authors of Stefan Blaas

This figure shows the co-authorship network connecting the top 25 collaborators of Stefan Blaas. A scholar is included among the top collaborators of Stefan Blaas based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Stefan Blaas. Stefan Blaas is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Blaas, Stefan, Michael Pfeifer, Maximilian Malfertheiner, et al.. (2025). Hyper-reactivity of CD8+ T cells and high expression of IL-3 correlates with occurrence and severity of Long-COVID. Clinical Immunology. 277. 110502–110502. 2 indexed citations
2.
Fritsch, Jürgen, Stefan Blaas, Moritz Ochmann, et al.. (2024). Whole-genome sequencing reveals two prolonged simultaneous outbreaks involving Pseudomonas aeruginosa high-risk strains ST111 and ST235 with resistance to quaternary ammonium compounds. Journal of Hospital Infection. 145. 155–164. 5 indexed citations
3.
Werner, Maren Caroline Frogner, Heiko Siegmund, David Peterhoff, et al.. (2023). Scorpionfish BPI is highly active against multiple drug-resistant Pseudomonas aeruginosa isolates from people with cystic fibrosis. eLife. 12. 4 indexed citations
4.
Hamer, Okka W., et al.. (2022). Rasmussen Aneurysm: A Forgotten Complication. American Journal of Respiratory and Critical Care Medicine. 207(2). 206–207.
5.
Lange, Tobias, et al.. (2021). Cardiopulmonary exercise pattern in patients with persistent dyspnoea after recovery from COVID-19. Multidisciplinary Respiratory Medicine. 16(1). 732–732. 44 indexed citations
6.
Diel, Roland, Santiago Ewig, Stefan Blaas, et al.. (2019). Incidence of patients with non-cystic fibrosis bronchiectasis in Germany – A healthcare insurance claims data analysis. Respiratory Medicine. 151. 121–127. 15 indexed citations
7.
Marchetti, Nathaniel, Divay Chandra, Felix Herth, et al.. (2018). Endobronchial Coils Versus Lung Volume Reduction Surgery or Medical Therapy for Treatment of Advanced Homogenous Emphysema. Chronic Obstructive Pulmonary Diseases Journal of the COPD Foundation. 5(2). 87–96. 8 indexed citations
8.
Blaas, Stefan. (2017). Tuberkulose. DMW - Deutsche Medizinische Wochenschrift. 142(24). 1838–1842. 1 indexed citations
9.
Blaas, Stefan. (2017). Pneumocystis-jirovecii-Pneumonie bei Patienten mit Autoimmunerkrankungen. Zeitschrift für Rheumatologie. 76(9). 761–766. 1 indexed citations
10.
Blaas, Stefan, et al.. (2015). Mental health, serum biomarkers and survival in severe COPD: a pilot study. Multidisciplinary Respiratory Medicine. 11(1). 3–3. 8 indexed citations
11.
Slebos, Dirk‐Jan, Jorine E. Hartman, Karin Klooster, et al.. (2015). Bronchoscopic Coil Treatment for Patients with Severe Emphysema: A Meta-Analysis. Respiration. 90(2). 136–145. 37 indexed citations
12.
Deslée, Gaëtan, Karin Klooster, Martin Hetzel, et al.. (2014). Lung volume reduction coil treatment for patients with severe emphysema: a European multicentre trial. Thorax. 69(11). 980–986. 90 indexed citations
13.
Burki, Nausherwan K., Raj Mani, Felix Herth, et al.. (2013). A Novel Extracorporeal CO2 Removal System. CHEST Journal. 143(3). 678–686. 146 indexed citations
14.
Slebos, Dirk‐Jan, Armin Ernst, Stefan Blaas, Wolfgang Gesierich, & Felix Herth. (2010). Bronchoscopic Lung Volume Reduction Coil Treatment of Severe Heterogeneous Emphysema. CHEST Journal. 138(4). 829A–829A. 7 indexed citations
15.
Ehrenstein, Boris, Frank Hanses, Stefan Blaas, et al.. (2010). Perceived risks of adverse effects and influenza vaccination: a survey of hospital employees. European Journal of Public Health. 20(5). 495–499. 14 indexed citations
16.
Blaas, Stefan, et al.. (2008). Extensively drug resistant tuberculosis in a high income country: A report of four unrelated cases. BMC Infectious Diseases. 8(1). 60–60. 22 indexed citations
17.
Blaas, Stefan, et al.. (2008). CpG-oligodeoxynucleotides stimulate immunoglobulin A secretion in intestinal mucosal B cells. Clinical & Experimental Immunology. 155(3). 534–540. 45 indexed citations
18.
Aretz, Stefan, Dietlinde Stienen, Siegfried Uhlhaas, et al.. (2007). High proportion of large genomic deletions and a genotype–phenotype update in 80 unrelated families with juvenile polyposis syndrome. Journal of Medical Genetics. 44(11). 702–709. 151 indexed citations
19.
Audebert, Franz, Frank Hanses, Arne Schneidewind, et al.. (2007). Epidemiologie der schweren Sepsis an einem deutschen Universitätsklinikum. Medizinische Klinik. 102(3). 195–202. 2 indexed citations
20.
Blaas, Stefan, et al.. (2003). Pericarditis as primary manifestation of Mycobacterium bovis SSP. caprae infection. Diagnostic Microbiology and Infectious Disease. 47(2). 431–433. 10 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Vui Heng Chong Breakdown of academic impact, for papers by O Leopardi Breakdown of academic impact, for papers by Daniel Hoefer Breakdown of academic impact, for papers by Corinne Levy Breakdown of academic impact, for papers by José Echave-Sustaeta Breakdown of academic impact, for papers by H T Winer-Muram Breakdown of academic impact, for papers by Thomas Pfeiffer Breakdown of academic impact, for papers by Kristine E. Konopka Breakdown of academic impact, for papers by Hideaki Oka Breakdown of academic impact, for papers by Joyce S. Davis
Rankless by CCL
2026